| Typicality: | 0.250 |
| Saliency: | 0.000 |
| for a generic product | 9 | purpose |
| with hi-tech pharmacal | 3 | other |
| elite → partnered to develop → an intermediate | 3 |
| negative | neutral | positive |
| 0.004 | 0.848 | 0.148 |
| Raw frequency | 3 |
| Normalized frequency | 0.000 |
| Modifier score | 0.500 |
| Perplexity | 250.877 |